Overview

Nitrous Oxide for Major Depressive Disorder

Status:
Completed
Trial end date:
2021-03-31
Target enrollment:
Participant gender:
Summary
This study aims at investigating the persistence of antidepressant effect of Nitrous Oxide (N2O) for Treatment-Resistant Depression(TRD). The investigators also aim to assess the effect of N2O on the electroencephalograph, multimodal magnetic resonance imaging(MRI), blood cytokines, feces bacteria flora and neuropsychological performance in patients with TRD. The investigators further aim to identify the predictors of N2O's antidepressant effeect using the above techniques.
Phase:
Phase 2
Details
Lead Sponsor:
Lingjiang Li
Treatments:
Nitrous Oxide